Exact Mass: 452.2774

Exact Mass Matches: 452.2774

Found 58 metabolites which its exact mass value is equals to given mass value 452.2774, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6Z,8E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5S,6E,8Z,11Z,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

(2S)-2-(acetyloxy)-3-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

(2R)-3-(acetyloxy)-2-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

(2S)-3-(acetyloxy)-2-hydroxypropyl (5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoate

C25H40O7 (452.2774)


DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

(2S)-1-(Acetyloxy)-3-hydroxypropan-2-yl (5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

(2S)-2-(Acetyloxy)-3-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

(2R)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

(2S)-3-(Acetyloxy)-2-hydroxypropyl (5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoic acid

C25H40O7 (452.2774)


DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Briarellin P

Briarellin P

C25H40O7 (452.2774)


   

Laserpitinol

Laserpitinol

C25H40O7 (452.2774)


   

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

C25H40O7 (452.2774)


   

grindelic acid 15-O-arabinoside

grindelic acid 15-O-arabinoside

C25H40O7 (452.2774)


   

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

C25H40O7 (452.2774)


   
   

dothideomycetone B

dothideomycetone B

C25H40O7 (452.2774)


   

5,6-acetonylgrayanotoxin-I

5,6-acetonylgrayanotoxin-I

C25H40O7 (452.2774)


   

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

C25H40O7 (452.2774)


   

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

C25H40O7 (452.2774)


   

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

C25H40O7 (452.2774)


   
   

Sarcoehrendin I

methyl-9S-hydroxy-11R,15S-diacetoxy-6Z,13E-prostadienoate

C25H40O7 (452.2774)


   

N-hexadecanoyl-sn-glycero-3-phosphoethanolamine(1-)

N-hexadecanoyl-sn-glycero-3-phosphoethanolamine(1-)

C21H43NO7P- (452.2777)


   

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.2774)


   

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.2774)


   

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.2774)


   

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

C25H40O7 (452.2774)


   

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C25H40O7 (452.2774)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

C25H40O7 (452.2774)


   

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C25H40O7 (452.2774)


   

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

C25H40O7 (452.2774)


   

epiandrosterone 3-beta-D-glucoside

epiandrosterone 3-beta-D-glucoside

C25H40O7 (452.2774)


A sterol 3-beta-D-glucoside that has epiandrosterone as the sterol component.

   

2-[[(2R)-2-acetyloxy-3-undec-10-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-2-acetyloxy-3-undec-10-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.2777)


   

2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.2777)


   

lysophosphatidylethanolamine zwitterion 16:0

lysophosphatidylethanolamine zwitterion 16:0

C21H43NO7P (452.2777)


A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 16 carbons and 0 double bonds.

   

ST 19:0;O;GlcA

ST 19:0;O;GlcA

C25H40O7 (452.2774)


   

ST 19:1;O2;Hex

ST 19:1;O2;Hex

C25H40O7 (452.2774)


   
   

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17s)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)


   

12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.2774)


   

15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)


   

(1r,2s,3s,5s,7r,8r,9s,10s,11r,16s,18r)-12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

(1r,2s,3s,5s,7r,8r,9s,10s,11r,16s,18r)-12,12-dimethyl-16-(3-methylbutoxy)-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecane-3,7,9,10,18-pentol

C25H40O7 (452.2774)


   

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

(1r,4ar,5s,8s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a,6-trimethyl-8-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

(1r,4ar,5s,8s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a,6-trimethyl-8-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.2774)


   

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5r,6s,7r,8ar)-7-hydroxy-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

1-{7-hydroxy-5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

1-{7-hydroxy-5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

C25H40O7 (452.2774)


   

(1s,2e,4s,6e)-1-[(1r,2s,5r,6s)-5-hydroxy-4-(hydroxymethyl)-2-[(2-hydroxypropan-2-yl)oxy]-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3,7,11-trimethyldodeca-2,6,10-triene-1,4-diol

(1s,2e,4s,6e)-1-[(1r,2s,5r,6s)-5-hydroxy-4-(hydroxymethyl)-2-[(2-hydroxypropan-2-yl)oxy]-7-oxabicyclo[4.1.0]hept-3-en-1-yl]-3,7,11-trimethyldodeca-2,6,10-triene-1,4-diol

C25H40O7 (452.2774)


   

(1r,2s,5r,6s)-1-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-{[(2-hydroxypropan-2-yl)oxy]methyl}-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol

(1r,2s,5r,6s)-1-[(1s,2e,4s,6e)-1,4-dihydroxy-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]-4-{[(2-hydroxypropan-2-yl)oxy]methyl}-7-oxabicyclo[4.1.0]hept-3-ene-2,5-diol

C25H40O7 (452.2774)


   

5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a,6-trimethyl-8-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a,6-trimethyl-8-[(3,4,5-trihydroxyoxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carbaldehyde

C25H40O7 (452.2774)


   

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17r)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

(1s,2s,3r,4r,7r,8r,11s,14r,15r,17r)-15-hydroxy-14-methoxy-4,8,11,15-tetramethyl-9-oxo-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl butanoate

C25H40O7 (452.2774)